Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Generalized Anxiety Disorder (Disease Or Phenotype)

Nci:C92622

Mondo:MONDO:1942

Medcin:MEDCIN:32777

Mdr:MDR:10018105

Id:d9ea20e0-8326-505b-81a4-a7a70197edb5

Icpc2icd10eng:MTHU006466

Icd10cm:F41.1

Efo:EFO:1001892

Doid:DOID:14320

Chv:CHV:26482

Results found

Linked to

	Label	Description
	SID11110983 indication Generalized Anxiety Disorder Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	alprazolam indication Generalized Anxiety Disorder Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	venlafaxine indication Generalized Anxiety Disorder Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Paroxetine indication Generalized Anxiety Disorder Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	8-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione (Buspirone) indication Generalized Anxiety Disorder Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Pregabalin indication Generalized Anxiety Disorder Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Duloxetine indication Generalized Anxiety Disorder Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	citalopram indication Generalized Anxiety Disorder Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

SID11110983 indication Generalized Anxiety Disorder

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

alprazolam indication Generalized Anxiety Disorder

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

venlafaxine indication Generalized Anxiety Disorder

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Paroxetine indication Generalized Anxiety Disorder

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

8-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione (Buspirone) indication Generalized Anxiety Disorder

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Pregabalin indication Generalized Anxiety Disorder

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Duloxetine indication Generalized Anxiety Disorder

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

citalopram indication Generalized Anxiety Disorder

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.